LONDON - Brussels on Wednesday published a long-awaited draft of its proposed overhaul of laws governing the European Union’s pharmaceuticals industry, setting up a tussle with drugmakers which warn they will invest and innovate elsewhere.
The Commission proposes to cut the length of basic market exclusivity that drugmakers get before generics can enter the market from 10 to eight years. Following publication, the European Parliament, Commission and member states will now thrash out final details of the law, which could take years.
เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม: